LOXL2 and prostate carcinoma: By data mining of high-throughput microarray data of prostate cancer cell lines deposited in the GEO database, LOXL2 was found to be significantly upregulated in all three CRPC cell lines as compared with the androgen-dependent prostate cancer cell lines.